Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with ImageJ. Biophotonics Int 11(7):36–42

Google Scholar 

Beique JC, Imad M, Mladenovic L, Gingrich JA, Andrade R (2007) Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex. Proc Natl Acad Sci USA 104:9870–9875

Article  PubMed  CAS  Google Scholar 

Benedetti F, Barbini B, Bernasconi A, Fulgosi MC, Colombo C, Dallaspezia S, Gavinelli C, Marino E, Pirovano A, Radaelli D, Smeraldi E (2008) Serotonin 5-HT_2A receptor gene variants influence antidepressant response to repeated total sleep deprivation in bipolar depression. Prog Neuropsychopharmacol Biol Psychiatry 32:1863–1866

Article  CAS  PubMed  Google Scholar 

Benneyworth MA, Smith RL, Barrett RJ, Sanders-Bush E (2005) Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice. Psychopharmacology (Berl) 179:854–862

Article  CAS  Google Scholar 

Berendsen HH, Broekkamp CL (1990) Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice. Br J Pharmacol 101:667–673

CAS  PubMed  Google Scholar 

Berg KA, Clarke WP, Cunningham KA, Spampinato U (2008) Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications. Neuropharmacology 55:969–976

Article  CAS  PubMed  Google Scholar 

Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, Emeson RB (1997) Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387:303–308

Article  CAS  PubMed  Google Scholar 

Burris KD, Breeding M, Sanders-Bush E (1991) (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist. J Pharmacol Exp Ther 258:891–896

CAS  PubMed  Google Scholar 

Cohen S (1953) The toxic psychoses and allied states. Am J Med 15:813–828

Article  CAS  PubMed  Google Scholar 

Cussac D, Newman-Tancredi A, Duqueyroix D, Pasteau V, Millan MJ (2002) Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking. Mol Pharmacol 62:578–589

Article  CAS  PubMed  Google Scholar 

Cussac D, Boutet-Robinet E, Ailhaud MC, Newman-Tancredi A, Martel JC, Danty N, Rauly-Lestienne I (2008) Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C -VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells. Eur J Pharmacol 594:32–38

Article  CAS  PubMed  Google Scholar 

Damjanoska KJ, Heidenreich BA, Kindel GH, D'Souza DN, Zhang Y, Garcia F, Battaglia G, Wolf WA, Van de Kar LD, Muma NA (2004) Agonist-induced serotonin 2A receptor desensitization in the rat frontal cortex and hypothalamus. J Pharmacol Exp Ther 309:1043–1050

Article  CAS  PubMed  Google Scholar 

De Deurwaerdere P, Navailles S, Berg KA, Clarke WP, Spampinato U (2004) Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J Neurosci 24:3235–3241

Article  PubMed  CAS  Google Scholar 

Dunlop J, Lock T, Jow B, Sitzia F, Grauer S, Jow F, Kramer A, Bowlby MR, Randall A, Kowal D, Gilbert A, Comery TA, Larocque J, Soloveva V, Brown J, Roncarati R (2009) Old and new pharmacology: positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine(2B/C) receptor antagonist SB-206553 (3, 5-dihydro-5-methyl-N-3-pyridinylbenzo[1, 2-b:4, 5-b']di pyrrole-1(2H)-carboxamide). J Pharmacol Exp Ther 328:766–776

Article  CAS  PubMed  Google Scholar 

Fiorella D, Helsley S, Lorrain DS, Rabin RA, Winter JC (1995a) The role of the 5-HT_2A and 5-HT_2C receptors in the stimulus effects of hallucinogenic drugs. III: the mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion. Psychopharmacology (Berl) 121:364–372

Article  CAS  Google Scholar 

Fiorella D, Rabin RA, Winter JC (1995b) Role of 5-HT_2A and 5-HT_2C receptors in the stimulus effects of hallucinogenic drugs. II: reassessment of LSD false positives. Psychopharmacology (Berl) 121:357–363

Article  CAS  Google Scholar 

Fischer R, Georgi F, Weber R (1951) Psychophysical correlations. VIII. Experimental tests in schizophrenia: lysergic acid diethylamide and mescaline. Schweiz Med Wochenschr 81:817–819, contd

CAS  PubMed  Google Scholar 

Fitzgerald LW, Conklin DS, Krause CM, Marshall AP, Patterson JP, Tran DP, Iyer G, Kostich WA, Largent BL, Hartig PR (1999) High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT_2A and 5-HT_2C receptors: evidence favoring the ternary complex and two-state models of agonist action. J Neurochem 72:2127–2134

Article  CAS  PubMed  Google Scholar 

Fletcher PJ, Tampakeras M, Sinyard J, Slassi A, Isaac M, Higgins GA (2009) Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice. Neuropharmacology 57(3):259–267

Article  CAS  PubMed  Google Scholar 

Freedman DX (1986) “Hallucinogenic drug research--if so, who what?: Symposium summary and Commentary”. Pharmacol Biochem Behav 24:407–415

Article  Google Scholar 

Freedman DX, Boggan WO (1982) Biochemical pharmacology of psychotomimetics. Springer-Verlag, Berlin

Garcia EE, Smith RL, Sanders-Bush E (2007) Role of G(q) protein in behavioral effects of the hallucinogenic drug 1-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane. Neuropharmacology 52:1671–1677

Article  CAS  PubMed  Google Scholar 

Gobert A, Millan MJ (1999) Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats. Neuropharmacology 38:315–317

Article  CAS  PubMed  Google Scholar 

Gobert A, Rivet JM, Lejeune F, Newman-Tancredi A, Adhumeau-Auclair A, Nicolas JP, Cistarelli L, Melon C, Millan MJ (2000) Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 36:205–221

Article  CAS  PubMed  Google Scholar 

Gonzalez-Measo J, Sealfon SC (2009) Agonist-trafficking and hallucinogens. Curr Med Chem 16(8):1017–1027

Article  Google Scholar 

Gonzalez-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, Gingrich JA (2007) Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 53:439–452

Article  CAS  PubMed  Google Scholar 

Halberstadt AL, van der Heijden I, Ruderman MA, Risbrough VB, Gingrich JA, Geyer MA, Powell SB (2009) 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice. Neuropsychopharmacology 34:1958–1967

Article  CAS  PubMed  Google Scholar 

Herrick-Davis K, Grinde E, Teitler M (2000) Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors. J Pharmacol Exp Ther 295:226–232

CAS  PubMed  Google Scholar 

Herrmann WM, Horowski R, Dannehl K, Kramer U, Lurati K (1977) Clinical effectiveness of lisuride hydrogen maleate: a double-blind trial versus methysergide. Headache 17:54–60

Article  CAS  PubMed  Google Scholar 

Hollister LE (1964) Chemical psychoses. Annu Rev Med 15:203–214

Article  CAS  PubMed  Google Scholar 

Jennings KA, Sheward WJ, Harmar AJ, Sharp T (2008) Evidence that genetic variation in 5-HT transporter expression is linked to changes in 5-HT_2A receptor function. Neuropharmacology 54:776–783

Article  CAS  PubMed  Google Scholar 

Kang K, Huang XF, Wang Q, Deng C (2009) Decreased density of serotonin 2A receptors in the superior temporal gyrus in schizophrenia-a postmortem study. Prog Neuropsychopharmacol Biol Psychiatry 33:867–871

Article  CAS  PubMed  Google Scholar 

Kettle CJ, Cheetham SC, Martin KF, Prow MR, Heal DJ (1999) The effects of the peptide-coupling agent, EEDQ, on 5-HT_2A receptor binding and function in rat frontal cortex. Neuropharmacology 38:1421–1430

Article  CAS  PubMed  Google Scholar 

Knight AR, Misra A, Quirk K, Benwell K, Revell D, Kennett G, Bickerdike M (2004) Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors. Naunyn Schmiedebergs Arch Pharmacol 370:114–123

Article  CAS  PubMed  Google Scholar 

Krall CM, Richards JB, Rabin RA, Winter JC (2008) Marked decrease of LSD-induced stimulus control in serotonin transporter knockout mice. Pharmacol Biochem Behav 88:349–357

Article  CAS  PubMed  Google Scholar 

Leggio GM, Cathala A, Moison D, Cunningham KA, Piazza PV, Spampinato U (2009) Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens. Neuropharmacology 56:507–513

Article  CAS  PubMed  Google Scholar 

Lopez-Gimenez JF, Mengod G, Palacios JM, Vilaro MT (1997) Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100, 907. Naunyn Schmiedebergs Arch Pharmacol 356:446–454

Article  CAS  PubMed  Google Scholar 

Lopez-Gimenez JF, Vilaro MT, Palacios JM, Mengod G (2001) Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL100, 907 autoradiography and in situ hybridization studies. J Comp Neurol 429:571–589

Article  CAS  PubMed  Google Scholar 

Lopez-Gimenez JF, Tecott LH, Palacios JM, Mengod G, Vilaro MT (2002) Serotonin 5- HT (2C) receptor knockout mice: autoradiographic analysis of multiple serotonin receptors. J Neurosci Res 67:69–85

Article  CAS  PubMed  Google Scholar 

Marek GJ, Aghajanian GK (1996) LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT_2A receptors on interneurons in rat piriform cortex. J Pharmacol Exp Ther 278:1373–1382

CAS  PubMed  Google Scholar 

Millan MJ (2005) Serotonin 5-HT_2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies. Therapie 60:441–460

PubMed  Google Scholar 

Millan MJ, Dekeyne A, Gobert A (1998) Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 37:953–955

Article  CAS  PubMed  Google Scholar 

Nichols DE (2004) Hallucinogens. Pharmacol Ther 101:131–181

Article  CAS  PubMed  Google Scholar 

Paxinos G, Watson KBJ (2004) The mouse brain in stereotaxic coordinates, 2nd edn. Elsevier Academic Press, Amsterdam, Boston

Google Scholar 

Quednow BB, Schmechtig A, Ettinger U, Petrovsky N, Collier DA, Vollenweider FX, Wagner M, Kumari V (2009) Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catechol-o-methyltransferase, but not on neuregulin-1 Arg38Gln genotype: a replication study. Biol Psychiatry 66(6):614–620

Article  CAS  PubMed  Google Scholar 

Roth BL, Ciaranello RD, Meltzer HY (1992) Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors. J Pharmacol Exp Ther 260:1361–1365

CAS  PubMed  Google Scholar 

Sanders-Bush E, Breeding M (1991) Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs. Psychopharmacology (Berl) 105:340–346

Article  CAS  Google Scholar 

Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101–1108

Article  CAS  PubMed  Google Scholar 

Schreiber R, Brocco M, Millan MJ (1994) Lockade of the discriminative stimulus effects of DOI by MDL 100,907 and the ‘atypical’ antipsychotics, clozapine and risperidone. Eur J Pharmacol 264:99–102

Article  CAS  PubMed  Google Scholar 

Smith RL, Barrett RJ, Sanders-Bush E (2003) Discriminative stimulus properties of 1-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/−)DOI] in C57BL/6J mice. Psychopharmacology (Berl) 166:61–68

CAS  Google Scholar 

Tecott LH, Sun LM, Akana SF, Strack AM, Lowenstein DH, Dallman MF, Julius D (1995) Eating disorder and epilepsy in mice lacking 5-HT_2C serotonin receptors. Nature 374:542–546

Article  CAS  PubMed  Google Scholar 

Vickers SP, Easton N, Malcolm CS, Allen NH, Porter RH, Bickerdike MJ, Kennett GA (2001) Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists. Pharmacol Biochem Behav 69:643–652

Article  CAS  PubMed  Google Scholar 

Vollenweider FX, Leenders KL, Scharfetter C, Maguire P, Stadelmann O, Angst J (1997) Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharmacology 16:357–372

Article  CAS  PubMed  Google Scholar 

Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Babler A, Vogel H, Hell D (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. NeuroReport 9:3897–3902

Article  CAS  PubMed  Google Scholar 

Weisstaub NV, Zhou M, Lira A, Lambe E, Gonzalez-Maeso J, Hornung JP, Sibille E, Underwood M, Itohara S, Dauer WT, Ansorge MS, Morelli E, Mann JJ, Toth M, Aghajanian G, Sealfon SC, Hen R, Gingrich JA (2006) Cortical 5-HT_2A receptor signaling modulates anxiety-like behaviors in mice. Science 313:536–540

Article  CAS  PubMed  Google Scholar 

Willins DL, Meltzer HY (1997) Direct injection of 5-HT_2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther 282:699–706

CAS  PubMed  Google Scholar 

Winter JC (2009) Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines. Psychopharmacology (Berl) 203:251–263

Article  CAS  Google Scholar 

Wolf WA, Schutz LJ (1997) The serotonin 5-HT_2C receptor is a prominent serotonin receptor in basal ganglia: evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis. J Neurochem 69:1449–1458

Article  CAS  PubMed  Google Scholar